Delivery Order SPE2DB22D2007-SPE2DB25FJ4AZ
- Not listed
- The Defense Logistics Agency awarded a $2,080.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Albumin (Human) 25% intravenous solution in 50ml units. The contract, which is not set-aside, will be performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with DLA,...
- The Defense Logistics Agency awarded a $1,255.80 delivery order to AmerisourceBergen Drug Corp for Albumin (Human) 5% IV Solution 250ml, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,040.20 to AmerisourceBergen Drug Corp for Albumin (Human) 25% IV Solution 50ML, with an ultimate completion date of September 5, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The product will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $9,984.96 to AmerisourceBergen Drug Corp for the supply of Albumin (Human) 25% intravenous solution in 100mL units. This competitively awarded, firm fixed-price contract was executed on August 12, 2025, with an ultimate completion date of September 3, 2025. The award carries no set-aside designation, indicating it was competed among qualified vendors. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Albumin (Human) 25% intravenous solution in 100 mL units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,080.20 and is scheduled for completion by August 26, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. As a non-set-aside contract, this award was made through open competition and...
- On August 1, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,496.56 to AmerisourceBergen Drug Corp for the supply of Albumin (Human) 25% Intravenous Solution in 100-milliliter units. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major...
- This is a $1,668.10 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ALBUMIN (HUMAN) 25% IV SOLN 50ML. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. This delivery order is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.20 firm-fixed-price delivery order is for the supply of Albumin (Human) 25% IV Solution, a pharmaceutical product used in medical care. The contract has an ultimate completion date of November 13, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albumin (Human) 25% IV Solution, 100 milliliters, with a ceiling value of $4,992.48 and a completion date of July 28, 2025. The contract is a Firm Fixed Price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albumin (Human) 5% IV Solution 250ml, a critical medical commodity, to support military healthcare programs. The contract has a ceiling value of $1,148.00 and a period of performance through April 1, 2025. It is a Firm Fixed Price contract, without any set-aside designation,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4AZDelivery Order
The Defense Logistics Agency awarded a $2,080.40 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Albumin (Human) 25% Intravenous Solution, 50mL. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. As a child contract, this delivery order falls within the comprehensive pharmaceutical support vehicle that enables AmerisourceBergen to supply critical medical commodities to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency. The company's DLA prime contract encompasses a broad range of pharmaceutical products and medical supplies including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for human albumin reflects the company's ongoing role as a critical vendor supporting military and federal healthcare systems' demand for essential pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/18/25 |